Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roifman

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
The Journal of Allergy and Clinical Immunology|November 29, 2017
Dual loss of p110δ PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic featuresNigel Sharfe, Ariana Karanxha, Harjit Dadi, et al.
Eye (London, England)|May 24, 2023
Deep phenotypic characterization of the retinal dystrophy in patients with RNU4ATAC-associated Roifman syndromeBrian G Ballios, Amarilla Mandola, Alaa Tayyib, et al.
Pediatric Research|January 9, 2004
Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphologyYigal Dror, Eyal Grunebaum, Johann Hitzler, et al.
The Journal of Pediatrics|February 1, 1992
Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritisR Schneider, B A Lang, B J Reilly, et al.
Molecular Immunology|June 1, 1991
Expression of the human T cell receptor V beta repertoireP J Doherty, C M Roifman, S H Pan, et al.
Human Molecular Genetics|April 1, 1995
Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspotH B Gaspar, L A Bradley, F Katz, et al.
The Journal of Clinical Investigation|May 1, 1990
X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findingsM E Conley, R H Buckley, R Hong, et al.
International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2011
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiencyEyal Grunebaum, Catherine T-S Chung, Harjit Dadi, et al.
NPJ Genomic Medicine|December 22, 2017
A homozygous mutation in the stem II domain of <i>RNU4ATAC</i> causes typical Roifman syndromeYael Dinur Schejter, Adi Ovadia, Roumiana Alexandrova, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
The Journal of Allergy and Clinical Immunology|November 29, 2017
Dual loss of p110δ PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic featuresNigel Sharfe, Ariana Karanxha, Harjit Dadi, et al.
Eye (London, England)|May 24, 2023
Deep phenotypic characterization of the retinal dystrophy in patients with RNU4ATAC-associated Roifman syndromeBrian G Ballios, Amarilla Mandola, Alaa Tayyib, et al.
Pediatric Research|January 9, 2004
Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphologyYigal Dror, Eyal Grunebaum, Johann Hitzler, et al.
The Journal of Pediatrics|February 1, 1992
Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritisR Schneider, B A Lang, B J Reilly, et al.
Molecular Immunology|June 1, 1991
Expression of the human T cell receptor V beta repertoireP J Doherty, C M Roifman, S H Pan, et al.
Human Molecular Genetics|April 1, 1995
Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspotH B Gaspar, L A Bradley, F Katz, et al.
The Journal of Clinical Investigation|May 1, 1990
X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findingsM E Conley, R H Buckley, R Hong, et al.
International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2011
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiencyEyal Grunebaum, Catherine T-S Chung, Harjit Dadi, et al.
NPJ Genomic Medicine|December 22, 2017
A homozygous mutation in the stem II domain of <i>RNU4ATAC</i> causes typical Roifman syndromeYael Dinur Schejter, Adi Ovadia, Roumiana Alexandrova, et al.
Pageof 23